Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.9.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GJ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.103NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GW.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.4.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.9.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FR.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.4.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HH.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.85NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FU.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.503NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.31NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.623NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.214.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.210NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.567NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.541NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.189NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used